nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadodiamide—Urinary tract disorder—Docetaxel—pancreatic cancer	0.00159	0.00159	CcSEcCtD
Gadodiamide—Abdominal pain—Sunitinib—pancreatic cancer	0.00159	0.00159	CcSEcCtD
Gadodiamide—Body temperature increased—Sunitinib—pancreatic cancer	0.00159	0.00159	CcSEcCtD
Gadodiamide—Diarrhoea—Erlotinib—pancreatic cancer	0.00159	0.00159	CcSEcCtD
Gadodiamide—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00159	0.00159	CcSEcCtD
Gadodiamide—Oedema—Fluorouracil—pancreatic cancer	0.00159	0.00159	CcSEcCtD
Gadodiamide—Nervous system disorder—Gemcitabine—pancreatic cancer	0.00159	0.00159	CcSEcCtD
Gadodiamide—Urethral disorder—Docetaxel—pancreatic cancer	0.00158	0.00158	CcSEcCtD
Gadodiamide—Hyponatraemia—Epirubicin—pancreatic cancer	0.00158	0.00158	CcSEcCtD
Gadodiamide—Infection—Fluorouracil—pancreatic cancer	0.00158	0.00158	CcSEcCtD
Gadodiamide—Renal failure acute—Doxorubicin—pancreatic cancer	0.00158	0.00158	CcSEcCtD
Gadodiamide—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00156	0.00156	CcSEcCtD
Gadodiamide—Nervous system disorder—Fluorouracil—pancreatic cancer	0.00156	0.00156	CcSEcCtD
Gadodiamide—Hot flush—Doxorubicin—pancreatic cancer	0.00156	0.00156	CcSEcCtD
Gadodiamide—Visual impairment—Docetaxel—pancreatic cancer	0.00156	0.00156	CcSEcCtD
Gadodiamide—Dizziness—Tamoxifen—pancreatic cancer	0.00156	0.00156	CcSEcCtD
Gadodiamide—Tachycardia—Fluorouracil—pancreatic cancer	0.00155	0.00155	CcSEcCtD
Gadodiamide—Hypotension—Irinotecan—pancreatic cancer	0.00155	0.00155	CcSEcCtD
Gadodiamide—Migraine—Epirubicin—pancreatic cancer	0.00155	0.00155	CcSEcCtD
Gadodiamide—Menopausal symptoms—Doxorubicin—pancreatic cancer	0.00154	0.00154	CcSEcCtD
Gadodiamide—Dizziness—Erlotinib—pancreatic cancer	0.00154	0.00154	CcSEcCtD
Gadodiamide—Renal impairment—Doxorubicin—pancreatic cancer	0.00153	0.00153	CcSEcCtD
Gadodiamide—Hypotension—Gemcitabine—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Gadodiamide—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Gadodiamide—Flushing—Docetaxel—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Gadodiamide—Vomiting—Tamoxifen—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Gadodiamide—Cardiac failure—Doxorubicin—pancreatic cancer	0.00149	0.00149	CcSEcCtD
Gadodiamide—Paraesthesia—Irinotecan—pancreatic cancer	0.00149	0.00149	CcSEcCtD
Gadodiamide—Hypotension—Fluorouracil—pancreatic cancer	0.00149	0.00149	CcSEcCtD
Gadodiamide—Hypersensitivity—Sunitinib—pancreatic cancer	0.00148	0.00148	CcSEcCtD
Gadodiamide—Rash—Tamoxifen—pancreatic cancer	0.00148	0.00148	CcSEcCtD
Gadodiamide—Dermatitis—Tamoxifen—pancreatic cancer	0.00148	0.00148	CcSEcCtD
Gadodiamide—Ataxia—Epirubicin—pancreatic cancer	0.00148	0.00148	CcSEcCtD
Gadodiamide—Vomiting—Erlotinib—pancreatic cancer	0.00148	0.00148	CcSEcCtD
Gadodiamide—Dyspnoea—Irinotecan—pancreatic cancer	0.00148	0.00148	CcSEcCtD
Gadodiamide—Somnolence—Irinotecan—pancreatic cancer	0.00148	0.00148	CcSEcCtD
Gadodiamide—Blood creatinine increased—Epirubicin—pancreatic cancer	0.00148	0.00148	CcSEcCtD
Gadodiamide—Headache—Tamoxifen—pancreatic cancer	0.00147	0.00147	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00147	0.00147	CcSEcCtD
Gadodiamide—Rash—Erlotinib—pancreatic cancer	0.00147	0.00147	CcSEcCtD
Gadodiamide—Dermatitis—Erlotinib—pancreatic cancer	0.00147	0.00147	CcSEcCtD
Gadodiamide—Hyponatraemia—Doxorubicin—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Gadodiamide—Dyspepsia—Irinotecan—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Gadodiamide—Headache—Erlotinib—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Gadodiamide—Paraesthesia—Gemcitabine—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Gadodiamide—Chills—Docetaxel—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Gadodiamide—Asthenia—Sunitinib—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Gadodiamide—Arrhythmia—Docetaxel—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Gadodiamide—Dyspnoea—Gemcitabine—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Gadodiamide—Somnolence—Gemcitabine—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Gadodiamide—Migraine—Doxorubicin—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Gadodiamide—Fatigue—Irinotecan—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Gadodiamide—Paraesthesia—Fluorouracil—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Gadodiamide—Pruritus—Sunitinib—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Gadodiamide—Pain—Irinotecan—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Gadodiamide—Dyspnoea—Fluorouracil—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Gadodiamide—Somnolence—Fluorouracil—pancreatic cancer	0.00141	0.00141	CcSEcCtD
Gadodiamide—Dyspepsia—Fluorouracil—pancreatic cancer	0.0014	0.0014	CcSEcCtD
Gadodiamide—Nausea—Tamoxifen—pancreatic cancer	0.0014	0.0014	CcSEcCtD
Gadodiamide—Fatigue—Gemcitabine—pancreatic cancer	0.00139	0.00139	CcSEcCtD
Gadodiamide—Pain—Gemcitabine—pancreatic cancer	0.00138	0.00138	CcSEcCtD
Gadodiamide—Nausea—Erlotinib—pancreatic cancer	0.00138	0.00138	CcSEcCtD
Gadodiamide—Diarrhoea—Sunitinib—pancreatic cancer	0.00138	0.00138	CcSEcCtD
Gadodiamide—Dysgeusia—Docetaxel—pancreatic cancer	0.00138	0.00138	CcSEcCtD
Gadodiamide—Ataxia—Doxorubicin—pancreatic cancer	0.00137	0.00137	CcSEcCtD
Gadodiamide—Feeling abnormal—Irinotecan—pancreatic cancer	0.00137	0.00137	CcSEcCtD
Gadodiamide—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Gadodiamide—Pain—Fluorouracil—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Gadodiamide—Dizziness—Sunitinib—pancreatic cancer	0.00133	0.00133	CcSEcCtD
Gadodiamide—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00133	0.00133	CcSEcCtD
Gadodiamide—Body temperature increased—Irinotecan—pancreatic cancer	0.00131	0.00131	CcSEcCtD
Gadodiamide—Abdominal pain—Irinotecan—pancreatic cancer	0.00131	0.00131	CcSEcCtD
Gadodiamide—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00131	0.00131	CcSEcCtD
Gadodiamide—Vomiting—Sunitinib—pancreatic cancer	0.00128	0.00128	CcSEcCtD
Gadodiamide—Body temperature increased—Gemcitabine—pancreatic cancer	0.00128	0.00128	CcSEcCtD
Gadodiamide—Rash—Sunitinib—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Gadodiamide—Dermatitis—Sunitinib—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Gadodiamide—Urticaria—Fluorouracil—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Gadodiamide—Headache—Sunitinib—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Gadodiamide—Syncope—Docetaxel—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Gadodiamide—Body temperature increased—Fluorouracil—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Gadodiamide—Loss of consciousness—Docetaxel—pancreatic cancer	0.00124	0.00124	CcSEcCtD
Gadodiamide—Hypersensitivity—Irinotecan—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Gadodiamide—Convulsion—Docetaxel—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Gadodiamide—Myalgia—Docetaxel—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Gadodiamide—Chest pain—Docetaxel—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Gadodiamide—Arthralgia—Docetaxel—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Gadodiamide—Nausea—Sunitinib—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Gadodiamide—Renal failure—Epirubicin—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Gadodiamide—Asthenia—Irinotecan—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Gadodiamide—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Gadodiamide—Dry mouth—Docetaxel—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Gadodiamide—Asthenia—Gemcitabine—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Gadodiamide—Oedema—Docetaxel—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Gadodiamide—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Gadodiamide—Pruritus—Gemcitabine—pancreatic cancer	0.00114	0.00114	CcSEcCtD
Gadodiamide—Infection—Docetaxel—pancreatic cancer	0.00114	0.00114	CcSEcCtD
Gadodiamide—Diarrhoea—Irinotecan—pancreatic cancer	0.00114	0.00114	CcSEcCtD
Gadodiamide—Shock—Docetaxel—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Gadodiamide—Nervous system disorder—Docetaxel—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Gadodiamide—Pruritus—Fluorouracil—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Gadodiamide—Tachycardia—Docetaxel—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Gadodiamide—Diarrhoea—Gemcitabine—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Gadodiamide—Renal failure—Doxorubicin—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Gadodiamide—Dizziness—Irinotecan—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Gadodiamide—Rhinitis—Epirubicin—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Gadodiamide—Diarrhoea—Fluorouracil—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Gadodiamide—Pharyngitis—Epirubicin—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Gadodiamide—Urinary tract disorder—Epirubicin—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Gadodiamide—Hypotension—Docetaxel—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Gadodiamide—Urethral disorder—Epirubicin—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Gadodiamide—Vomiting—Irinotecan—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Gadodiamide—Dizziness—Fluorouracil—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Gadodiamide—Visual impairment—Epirubicin—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Gadodiamide—Rash—Irinotecan—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Gadodiamide—Dermatitis—Irinotecan—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Gadodiamide—Headache—Irinotecan—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Gadodiamide—Paraesthesia—Docetaxel—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Gadodiamide—Vomiting—Gemcitabine—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Gadodiamide—Dyspnoea—Docetaxel—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Gadodiamide—Somnolence—Docetaxel—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Gadodiamide—Rash—Gemcitabine—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Gadodiamide—Dermatitis—Gemcitabine—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Gadodiamide—Tinnitus—Epirubicin—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Gadodiamide—Headache—Gemcitabine—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Gadodiamide—Flushing—Epirubicin—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Gadodiamide—Vomiting—Fluorouracil—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Gadodiamide—Rhinitis—Doxorubicin—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Gadodiamide—Dyspepsia—Docetaxel—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Gadodiamide—Rash—Fluorouracil—pancreatic cancer	0.001	0.001	CcSEcCtD
Gadodiamide—Dermatitis—Fluorouracil—pancreatic cancer	0.001	0.001	CcSEcCtD
Gadodiamide—Pharyngitis—Doxorubicin—pancreatic cancer	0.001	0.001	CcSEcCtD
Gadodiamide—Headache—Fluorouracil—pancreatic cancer	0.000996	0.000996	CcSEcCtD
Gadodiamide—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000995	0.000995	CcSEcCtD
Gadodiamide—Fatigue—Docetaxel—pancreatic cancer	0.000989	0.000989	CcSEcCtD
Gadodiamide—Urethral disorder—Doxorubicin—pancreatic cancer	0.000988	0.000988	CcSEcCtD
Gadodiamide—Nausea—Irinotecan—pancreatic cancer	0.000986	0.000986	CcSEcCtD
Gadodiamide—Pain—Docetaxel—pancreatic cancer	0.000981	0.000981	CcSEcCtD
Gadodiamide—Chills—Epirubicin—pancreatic cancer	0.000977	0.000977	CcSEcCtD
Gadodiamide—Arrhythmia—Epirubicin—pancreatic cancer	0.000973	0.000973	CcSEcCtD
Gadodiamide—Visual impairment—Doxorubicin—pancreatic cancer	0.000971	0.000971	CcSEcCtD
Gadodiamide—Nausea—Gemcitabine—pancreatic cancer	0.00096	0.00096	CcSEcCtD
Gadodiamide—Feeling abnormal—Docetaxel—pancreatic cancer	0.000946	0.000946	CcSEcCtD
Gadodiamide—Nausea—Fluorouracil—pancreatic cancer	0.000944	0.000944	CcSEcCtD
Gadodiamide—Tinnitus—Doxorubicin—pancreatic cancer	0.00094	0.00094	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000938	0.000938	CcSEcCtD
Gadodiamide—Flushing—Doxorubicin—pancreatic cancer	0.000935	0.000935	CcSEcCtD
Gadodiamide—Dysgeusia—Epirubicin—pancreatic cancer	0.000929	0.000929	CcSEcCtD
Gadodiamide—Body temperature increased—Docetaxel—pancreatic cancer	0.000907	0.000907	CcSEcCtD
Gadodiamide—Abdominal pain—Docetaxel—pancreatic cancer	0.000907	0.000907	CcSEcCtD
Gadodiamide—Chills—Doxorubicin—pancreatic cancer	0.000904	0.000904	CcSEcCtD
Gadodiamide—Arrhythmia—Doxorubicin—pancreatic cancer	0.0009	0.0009	CcSEcCtD
Gadodiamide—Ill-defined disorder—Epirubicin—pancreatic cancer	0.00088	0.00088	CcSEcCtD
Gadodiamide—Dysgeusia—Doxorubicin—pancreatic cancer	0.000859	0.000859	CcSEcCtD
Gadodiamide—Malaise—Epirubicin—pancreatic cancer	0.000855	0.000855	CcSEcCtD
Gadodiamide—Syncope—Epirubicin—pancreatic cancer	0.00085	0.00085	CcSEcCtD
Gadodiamide—Hypersensitivity—Docetaxel—pancreatic cancer	0.000845	0.000845	CcSEcCtD
Gadodiamide—Loss of consciousness—Epirubicin—pancreatic cancer	0.000833	0.000833	CcSEcCtD
Gadodiamide—Asthenia—Docetaxel—pancreatic cancer	0.000823	0.000823	CcSEcCtD
Gadodiamide—Convulsion—Epirubicin—pancreatic cancer	0.000822	0.000822	CcSEcCtD
Gadodiamide—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000814	0.000814	CcSEcCtD
Gadodiamide—Pruritus—Docetaxel—pancreatic cancer	0.000812	0.000812	CcSEcCtD
Gadodiamide—Arthralgia—Epirubicin—pancreatic cancer	0.000807	0.000807	CcSEcCtD
Gadodiamide—Myalgia—Epirubicin—pancreatic cancer	0.000807	0.000807	CcSEcCtD
Gadodiamide—Chest pain—Epirubicin—pancreatic cancer	0.000807	0.000807	CcSEcCtD
Gadodiamide—Anxiety—Epirubicin—pancreatic cancer	0.000805	0.000805	CcSEcCtD
Gadodiamide—Discomfort—Epirubicin—pancreatic cancer	0.000798	0.000798	CcSEcCtD
Gadodiamide—Malaise—Doxorubicin—pancreatic cancer	0.000791	0.000791	CcSEcCtD
Gadodiamide—Dry mouth—Epirubicin—pancreatic cancer	0.00079	0.00079	CcSEcCtD
Gadodiamide—Syncope—Doxorubicin—pancreatic cancer	0.000787	0.000787	CcSEcCtD
Gadodiamide—Diarrhoea—Docetaxel—pancreatic cancer	0.000785	0.000785	CcSEcCtD
Gadodiamide—Oedema—Epirubicin—pancreatic cancer	0.000774	0.000774	CcSEcCtD
Gadodiamide—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000774	0.000774	CcSEcCtD
Gadodiamide—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000771	0.000771	CcSEcCtD
Gadodiamide—Infection—Epirubicin—pancreatic cancer	0.000769	0.000769	CcSEcCtD
Gadodiamide—Shock—Epirubicin—pancreatic cancer	0.000761	0.000761	CcSEcCtD
Gadodiamide—Convulsion—Doxorubicin—pancreatic cancer	0.00076	0.00076	CcSEcCtD
Gadodiamide—Nervous system disorder—Epirubicin—pancreatic cancer	0.000759	0.000759	CcSEcCtD
Gadodiamide—Dizziness—Docetaxel—pancreatic cancer	0.000759	0.000759	CcSEcCtD
Gadodiamide—Tachycardia—Epirubicin—pancreatic cancer	0.000755	0.000755	CcSEcCtD
Gadodiamide—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000748	0.000748	CcSEcCtD
Gadodiamide—Myalgia—Doxorubicin—pancreatic cancer	0.000747	0.000747	CcSEcCtD
Gadodiamide—Chest pain—Doxorubicin—pancreatic cancer	0.000747	0.000747	CcSEcCtD
Gadodiamide—Arthralgia—Doxorubicin—pancreatic cancer	0.000747	0.000747	CcSEcCtD
Gadodiamide—Anxiety—Doxorubicin—pancreatic cancer	0.000744	0.000744	CcSEcCtD
Gadodiamide—Discomfort—Doxorubicin—pancreatic cancer	0.000738	0.000738	CcSEcCtD
Gadodiamide—Dry mouth—Doxorubicin—pancreatic cancer	0.000731	0.000731	CcSEcCtD
Gadodiamide—Vomiting—Docetaxel—pancreatic cancer	0.00073	0.00073	CcSEcCtD
Gadodiamide—Rash—Docetaxel—pancreatic cancer	0.000723	0.000723	CcSEcCtD
Gadodiamide—Hypotension—Epirubicin—pancreatic cancer	0.000723	0.000723	CcSEcCtD
Gadodiamide—Dermatitis—Docetaxel—pancreatic cancer	0.000723	0.000723	CcSEcCtD
Gadodiamide—Headache—Docetaxel—pancreatic cancer	0.000719	0.000719	CcSEcCtD
Gadodiamide—Oedema—Doxorubicin—pancreatic cancer	0.000716	0.000716	CcSEcCtD
Gadodiamide—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000716	0.000716	CcSEcCtD
Gadodiamide—Infection—Doxorubicin—pancreatic cancer	0.000711	0.000711	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000705	0.000705	CcSEcCtD
Gadodiamide—Shock—Doxorubicin—pancreatic cancer	0.000705	0.000705	CcSEcCtD
Gadodiamide—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000702	0.000702	CcSEcCtD
Gadodiamide—Tachycardia—Doxorubicin—pancreatic cancer	0.000699	0.000699	CcSEcCtD
Gadodiamide—Paraesthesia—Epirubicin—pancreatic cancer	0.000695	0.000695	CcSEcCtD
Gadodiamide—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000692	0.000692	CcSEcCtD
Gadodiamide—Dyspnoea—Epirubicin—pancreatic cancer	0.00069	0.00069	CcSEcCtD
Gadodiamide—Somnolence—Epirubicin—pancreatic cancer	0.000688	0.000688	CcSEcCtD
Gadodiamide—Nausea—Docetaxel—pancreatic cancer	0.000682	0.000682	CcSEcCtD
Gadodiamide—Dyspepsia—Epirubicin—pancreatic cancer	0.000681	0.000681	CcSEcCtD
Gadodiamide—Hypotension—Doxorubicin—pancreatic cancer	0.000669	0.000669	CcSEcCtD
Gadodiamide—Fatigue—Epirubicin—pancreatic cancer	0.000667	0.000667	CcSEcCtD
Gadodiamide—Pain—Epirubicin—pancreatic cancer	0.000662	0.000662	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000652	0.000652	CcSEcCtD
Gadodiamide—Paraesthesia—Doxorubicin—pancreatic cancer	0.000643	0.000643	CcSEcCtD
Gadodiamide—Dyspnoea—Doxorubicin—pancreatic cancer	0.000638	0.000638	CcSEcCtD
Gadodiamide—Feeling abnormal—Epirubicin—pancreatic cancer	0.000638	0.000638	CcSEcCtD
Gadodiamide—Somnolence—Doxorubicin—pancreatic cancer	0.000637	0.000637	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000633	0.000633	CcSEcCtD
Gadodiamide—Dyspepsia—Doxorubicin—pancreatic cancer	0.00063	0.00063	CcSEcCtD
Gadodiamide—Fatigue—Doxorubicin—pancreatic cancer	0.000617	0.000617	CcSEcCtD
Gadodiamide—Urticaria—Epirubicin—pancreatic cancer	0.000615	0.000615	CcSEcCtD
Gadodiamide—Pain—Doxorubicin—pancreatic cancer	0.000612	0.000612	CcSEcCtD
Gadodiamide—Abdominal pain—Epirubicin—pancreatic cancer	0.000612	0.000612	CcSEcCtD
Gadodiamide—Body temperature increased—Epirubicin—pancreatic cancer	0.000612	0.000612	CcSEcCtD
Gadodiamide—Feeling abnormal—Doxorubicin—pancreatic cancer	0.00059	0.00059	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000586	0.000586	CcSEcCtD
Gadodiamide—Hypersensitivity—Epirubicin—pancreatic cancer	0.00057	0.00057	CcSEcCtD
Gadodiamide—Urticaria—Doxorubicin—pancreatic cancer	0.000569	0.000569	CcSEcCtD
Gadodiamide—Body temperature increased—Doxorubicin—pancreatic cancer	0.000566	0.000566	CcSEcCtD
Gadodiamide—Abdominal pain—Doxorubicin—pancreatic cancer	0.000566	0.000566	CcSEcCtD
Gadodiamide—Asthenia—Epirubicin—pancreatic cancer	0.000555	0.000555	CcSEcCtD
Gadodiamide—Pruritus—Epirubicin—pancreatic cancer	0.000548	0.000548	CcSEcCtD
Gadodiamide—Diarrhoea—Epirubicin—pancreatic cancer	0.00053	0.00053	CcSEcCtD
Gadodiamide—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000528	0.000528	CcSEcCtD
Gadodiamide—Asthenia—Doxorubicin—pancreatic cancer	0.000514	0.000514	CcSEcCtD
Gadodiamide—Dizziness—Epirubicin—pancreatic cancer	0.000512	0.000512	CcSEcCtD
Gadodiamide—Pruritus—Doxorubicin—pancreatic cancer	0.000507	0.000507	CcSEcCtD
Gadodiamide—Vomiting—Epirubicin—pancreatic cancer	0.000492	0.000492	CcSEcCtD
Gadodiamide—Diarrhoea—Doxorubicin—pancreatic cancer	0.00049	0.00049	CcSEcCtD
Gadodiamide—Rash—Epirubicin—pancreatic cancer	0.000488	0.000488	CcSEcCtD
Gadodiamide—Dermatitis—Epirubicin—pancreatic cancer	0.000488	0.000488	CcSEcCtD
Gadodiamide—Headache—Epirubicin—pancreatic cancer	0.000485	0.000485	CcSEcCtD
Gadodiamide—Dizziness—Doxorubicin—pancreatic cancer	0.000474	0.000474	CcSEcCtD
Gadodiamide—Nausea—Epirubicin—pancreatic cancer	0.00046	0.00046	CcSEcCtD
Gadodiamide—Vomiting—Doxorubicin—pancreatic cancer	0.000455	0.000455	CcSEcCtD
Gadodiamide—Rash—Doxorubicin—pancreatic cancer	0.000452	0.000452	CcSEcCtD
Gadodiamide—Dermatitis—Doxorubicin—pancreatic cancer	0.000451	0.000451	CcSEcCtD
Gadodiamide—Headache—Doxorubicin—pancreatic cancer	0.000449	0.000449	CcSEcCtD
Gadodiamide—Nausea—Doxorubicin—pancreatic cancer	0.000425	0.000425	CcSEcCtD
